Table 3. Comparative analysis of glycoconjugate expression of six human melanoma cell lines in vitro (a) and in vivo (b).
| Cell line | L1 | CEACAM-1 | bHPA | iHPA | WGA | PHA-L |
|---|---|---|---|---|---|---|
| (a) In vitro | ||||||
| G361 | +++ | ++ | + | + | +++ | +/++ |
| FemX-I | +++ | +++ | ++ | + | +++ | ++ |
| MeWo | ++ | − | + | ++ | +++ | + |
| MV3 | + | − | − | + | +++ | +++ |
| LOX | ++ | − | +++ | ++ | +++ | ++ |
| UISO-Mel6 | ++ | − | + | ++ | +++ | −/+/++ |
| (b) In vivo | ||||||
| G361 | + | ++ | + | +++ | +++ | − |
| FemX-I | + | +++ | +/++ | + | +++ | − |
| MeWo | +++ | + | ++ | +/++/+++ | +++ | − |
| MV3 | + | − | − | + | +++ | − |
| LOX | + | − | +++ | +++ | +++ | − |
| UISO-Mel6 | + | ++/+++ | + | + | +++ | − |
Expression of markers in vitro differed considerably from that of in vivo.